Literature DB >> 1354155

Zollinger-Ellison syndrome, antisecretory treatment, and body weight.

J L Raoul, J F Bretagne, A Ropert, L Siproudhis, D Heresbach, M Gosselin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1354155     DOI： 10.1007/bf01296581

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.

Authors:  C T Dourish; W Rycroft; S D Iversen
Journal:  Science       Date:  1989-09-29       Impact factor: 47.728

Review 2.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

3.  Impaired cholecystokinin secretion in bulimia nervosa.

Authors:  T D Geracioti; R A Liddle
Journal:  N Engl J Med       Date:  1988-09-15       Impact factor: 91.245
  3 in total
  2 in total

1.  Transmucosal gastric leak induced by proton pump inhibitors.

Authors:  Lisa J Murray; Melissa Gabello; David S Rudolph; Christopher P Farrell; Melissa Morgan; Aaron P Martin; James C Underwood; M Carmen Valenzano; James M Mullin
Journal:  Dig Dis Sci       Date:  2008-11-18       Impact factor: 3.199

Review 2.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.